Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, 184 rue du Faubourg Saint-Antoine, 75012 Paris, France.
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):107-13. doi: 10.1007/s10096-012-1724-5. Epub 2012 Aug 21.
The outcome of bacterial bloodstream infections during pregnancy has greatly improved over the last few decades. However, there are no recent data on the characteristics of bacteremia in pregnant women. The aim of this study was to describe clinical and microbiological features of bacteremia and to assess maternal and fetal outcome. This retrospective study was conducted in the obstetrics departments of five teaching hospitals in Paris, France, from 2005 to 2009. The incidence of bacteremia was 0.3%. The most common sources of bacteremia were chorioamnionitis (47%) and the most common pathogen isolated was Escherichia coli. Empirical antimicrobial therapy was inappropriate in 29% of bacteremia cases, mostly (65%) when secondary to infection with an aminopenicillin-resistant microorganism. Bacteremia during pregnancy was associated with a 10% fetal mortality. Bacteremia during pregnancy is a rare occurrence, but it is associated with an unexpectedly poor fetal outcome and a high mortality rate.
在过去几十年中,孕妇细菌性血流感染的结局已得到显著改善。然而,目前尚无关于孕妇菌血症特征的最新数据。本研究旨在描述菌血症的临床和微生物学特征,并评估母婴结局。这项回顾性研究于 2005 年至 2009 年在法国巴黎的五所教学医院的妇产科进行。菌血症的发生率为 0.3%。菌血症最常见的来源是绒毛膜羊膜炎(47%),最常见的分离病原体是大肠埃希菌。经验性抗菌治疗在 29%的菌血症病例中不适当,主要是(65%)当继发于耐氨苄西林的微生物感染时。孕妇菌血症与 10%的胎儿死亡率相关。孕妇菌血症虽较为罕见,但与不良胎儿结局和高死亡率相关。